Xia Liu

3PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jul 27, 2026
Targeting TOMM40 unleashes immunogenic mitophagy to facilitate antigen presentation and immunotherapy sensitization.

|Jul 27, 2024
The long-term effectiveness and mechanism of oncolytic virotherapy combined with anti-PD-L1 antibody in colorectal cancer patient.

Hangyu Zhang, Yiqing Ren, Feiyu Wang

|Mar 08, 2024
S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function.

Xiaoxuan Tu, Longxian Chen, Yi Zheng

Pageof 1

Frequent Collaborators

1 joint publications

Jianwen Li

1 joint publications

Weijia Fang

1 joint publications

Zhiwei Zhang

1 joint publications

Yu-An Xie

1 joint publications

Chenglin Mu

1 joint publications

Shiying Sheng

1 joint publications

Jinyuan Zhang

1 joint publications

Jie Han

1 joint publications

Jiwen Li

1 joint publications

Zhengfu He

Frequent Collaborators

1 joint publications

Jianwen Li

1 joint publications

Weijia Fang

1 joint publications

Zhiwei Zhang

1 joint publications

Yu-An Xie

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us